In vitro susceptibility study of Candida Spp. isolates to new combined potential medicinal product for the treatment of vaginal candidiasis
Journal Title: ScienceRise: Pharmaceutical Science - Year 2018, Vol 0, Issue 1
Abstract
<p>Research of the antimicrobial action of model specimens of a potential drug in various fixed combinations and the advent of specific antimycotic activity of model samples of a new, combined, potential drug and medicine product, selected as a reference "Neo-Penotran®" (Exeltis Healthcare S.L., Spain).</p><p><strong>Aim of the research</strong> was to determine the susceptibility of in vitro Candida spp. isolates to a new combined drug containing a substance with an antimycotic activity for the treatment of vaginal candidiasis.</p><p><strong>Materials and methods.</strong> Candida albicans (ATCC 10231) and Candida albicans (clinical isolate) from the material, urogenital pathways from women with a diagnosis of candidiasis were used to prove the activity and determine the sensitivity.</p><p>The study of antimicrobial activity was carried out using the serial dilutions method in trypticase-soybean broth, which allowed to ensure a uniform distribution of the drug in the nutrient medium in contact with pathogenic strains, and the subsequent transfer to Petri dishes on Sabouraud agar - the most accurate evaluation of the results.</p><p><strong>Results</strong> of the study of the antimycotic activity of 7 model specimens showed antimycotic activity in only 3 model specimens in relation to both the reference strain Candida albicans ATCC 10231 and the clinical strain of Candida albicans.</p><p><strong>Conclusions.</strong> The results of the studies indicate that there is a strong in vitro antimycotic effect of the new potential combined drug against pathogenic test strains: Candida albicans ATCC 10231, Candida albicans (clinical isolate), which is not inferior to the selected reference medicine. Minimum inhibitory concentration of the test drug in vitro was established for pathogenic test strains: Candida albicans ATCC 10231, Candida albicans (clinical isolate). The study of various combinations and concentrations of the combined drug made it possible to exclude the presence of negative interaction between components of the experimental specimen and to select the most promising and effective sample for further experimental studies of combinations of antimycotics for intravaginal use</p>
Authors and Affiliations
Iryna Nizhenkovska, Liudmyla Zinchenko
Вивчення стероїдних сполук у сировині канни садової
<p><strong>Мета. </strong>Ідентифікація та визначення кількісного вмісту стероїдних сполук у коренях, кореневищах, листках та квітках канни садової.</p><p><strong>Методи дослідження. </strong>Ідентифікацію стероїдних спо...
Development of method for qualitative analysis of corn silk for implementation in the state pharmacopoeia of Ukraine draft national monograph
According to the concept of development and implementation of monographs on herbal material into the State Pharmacopoeia of Ukraine, Corn silk is included into the list of herbal material, which is described in the State...
Development of the methodological approach of obtaining preparations based on solid dispersions
<p>Nowadays, the innovative direction of pharmaceutical development is the application of methods to increase the biopharmaceutical efficiency and safety of the use of already existing APIs, including method of incorpora...
Study of consumption of drugs for the treatment of soldiers as surgical patients in a military mobile hospital
<p><strong>The aim</strong> is to analyze the consumption of medicines for the treatment of soldiers as surgical patients in a military mobile hospital (hereinafter MMH).</p><p><strong>Methods.</strong> With the use of t...
Physico-chemical and pharmaco-technological research at a substantiation of rational composition and technology of suppositories «indoxam»
The development of new highly effective drugs in the form of rectal suppositories for the treatment of diseases of the prostate gland does not lose its relevance today, since the number of patients with these pathologies...